Lupin Pharmaceuticals Inc. is recalling 34,080 boxes of Tri-Lo-Marzia (norgestimate and ethinyl estradiol) birth control tablets. This recall was initiated after a review of test data revealed that the ingredients in the medication blend were not uniform, which can affect the consistency of the tablets produced from that batch. The affected products were distributed nationwide in the United States in cartons containing three 28-tablet wallets each.
The lack of blend uniformity means that individual tablets may contain more or less of the active hormone ingredients than intended. This could potentially lead to decreased effectiveness of the birth control or an increased risk of side effects.
Healthcare consultation and pharmacy refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.